• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients

    Author

    • Dr. U.T. Mane, Dr. Desai Jabbar V
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

The severity of the illness and the decline in health status of critical patients determine the mortality rate in ICUs. Extremes of age, disease severity, and certain pre-existing comorbidities like diabetes are the factors that contribute to higher hospital death rates (e.g. Malignancy, Immunosuppressed status and patients on renal replacement therapy). Florence Nightingale recognised the need for clinical treatment outcome assessment for the first time in 1863. 2
Initially, the ability and judgement of the doctor was used to predict the outcome in critically ill patients. In order to improve procedures that are mostly based on evidence, the recent rapid rise of intensive care units has necessitated a quantitative evaluation and review of the outcomes. The first disease severity scores and outcome prediction models were created more than 25 years ago with the goal of determining the probability of fatality in critically sick patients. Since then, other Intensive Care unit scoring systems have been created, taking aetiology and varied scenarios into account. As a result, determining the prognosis is an essential component of managing any critically ill cases. 3

  • XML
  • PDF 468.49 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 16
    • PDF Download: 22
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 1
January 2022
Page 1764-1777
Files
  • XML
  • PDF 468.49 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 16
  • PDF Download: 22

APA

Dr. Desai Jabbar V, D. U. M. (2022). Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients. European Journal of Molecular & Clinical Medicine, 9(1), 1764-1777.

MLA

Dr. U.T. Mane, Dr. Desai Jabbar V. "Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients". European Journal of Molecular & Clinical Medicine, 9, 1, 2022, 1764-1777.

HARVARD

Dr. Desai Jabbar V, D. U. M. (2022). 'Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients', European Journal of Molecular & Clinical Medicine, 9(1), pp. 1764-1777.

VANCOUVER

Dr. Desai Jabbar V, D. U. M. Procalcitonin Use in Sepsis Presentations Among Tertiary Care Patients. European Journal of Molecular & Clinical Medicine, 2022; 9(1): 1764-1777.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus